Equity Research, Broker Reports, and media content on Advanced Oncotherapy

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Advanced Oncotherapy
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Advanced Oncotherapy. We currently have 99 research reports from 5 professional analysts.

Open
N/A
Range Today
N/A
52 Week
35.5/52.0p
Daily Volume
N/A
# Shares
243.8m
Daily Liquidity
(0.01%)
Pension Liability
£0m
Enterprise Value
£92.9m
Market Cap
£91.4m
Latest PE (hist)
Div Yield
Date Source Announcement
04Dec19 07:15 EQS Hardman & Co Research: Advanced Oncotherapy (AVO): Proving the accuracy and superiority of minibeams
04Dec19 07:00 RNS Two-Year Collaborative Research Study
03Dec19 17:45 RNS Holding(s) in Company
29Nov19 17:00 RNS Total Voting Rights
28Nov19 10:15 RNS Holding(s) in Company
20Nov19 07:00 RNS Subscription to raise c.GBP 2.7 million
11Nov19 09:11 EQS Hardman & Co Research: Advanced Oncotherapy (AVO): FLASH benefits from new US reimbursement
  • Frequency of research reports

     

  • Research reports on

    Advanced Oncotherapy

  • Providers covering

    Advanced Oncotherapy